Diaceutics Plc (DXRX) Ord GBP0.002

- Add to watchlist
- Create an alert
- This stock can be held in a




Share news, reports & tips
-
Diaceutics secures $2m multi-year contract with global pharma company
13 June 2022 10:30
(Sharecast News) - Diagnostic commercialisation company Diaceutics has secured a multi-year contract win with an unnamed "top five" global pharmaceutical company to deliver customised data insights...
-
Diaceutics inks five-year deal with existing pharma partner
5 May 2022 12:58
(Sharecast News) - Diaceutics announced a five-year, multi-product subscription contract with an unnamed "top 30" global pharma company on Thursday, to deliver customised data insights via its...
-
Diaceutics secures $1m subscription contract with 'leading life sciences company'
14 December 2021 09:45
(Sharecast News) - Diagnostic commercialisation company Diaceutics said on Tuesday that it had secured a $1.0m contract with a "leading life sciences company" to provide data feed from its DXRX...
-
Diaceutics delivers 'strong start' to 2021 despite ongoing pandemic
8 July 2021 09:56
(Sharecast News) - Diagnostic commercialisation company Diaceutics said on Thursday that it had delivered "a strong start to the 2021 financial year", in line with management's expectations...
-
Diaceutics secures multiple contracts with 'leading' pharma firms
24 June 2021 10:15
(Sharecast News) - Diagnostics commercialisation company Diaceutics has secured four contracts with two "leading pharmaceutical companies" to solve real-world testing hurdles for inherited retinal...
-
Diaceutics wins data deal with unnamed pharma firm
1 April 2021 16:05
(Sharecast News) - Diaceutics has secured a data licensing agreement with an unnamed global pharmaceutical company to provide Covid-19 testing data insights in the US, it announced on Thursday, enabled by...
-
Diaceutics pleased with 2020 performance
11 January 2021 16:12
(Sharecast News) - Diaceutics updated the market on its trading in 2020 on Monday, reporting that its revenue and adjusted EBITDA for the year ended 31 December were expected to be around £12.6m, down from...
-
Diaceutics shares rise as it launches new diagnostic development platform
28 October 2020 13:48
(Sharecast News) - Diaceutics announced the launch of its 'DXRX - The Diagnostic Network digital platform on Wednesday, which it said was designed to accelerate the development and commercialisation of...
-
Diaceutics wins ?1m pharmaceutical client contract
22 July 2020 09:45
(Sharecast News) - Diagnostic commercialisation company Diaceutics announced a new, "significant" client contract win with an unnamed pharmaceutical company on Wednesday.
-
Diaceutics builds on strong Q1, trades in line
8 July 2020 08:06
(Sharecast News) - Diagnostic commercialisation company Diaceutics said on Wednesday that it had built on its good start to the financial year, with trading in the first half in line with expectations.
-
Diaceutics raising £20.5m ahead of launch of new platform
11 June 2020 12:33
(Sharecast News) - Diagnostics commercialisation company Diaceutics has conditionally raised £20.5m before expenses, through a placing of 14,137,931 new shares at 145p each to existing and new investors in...
-
Diaceutics maintains expectations after first quarter
19 May 2020 10:56
(Sharecast News) - Diaceutics said it had made a "good start" to the 2020 financial year on Tuesday, with trading in the first quarter in line with the board's expectations.
Company announcements Announcements
-
Multi-year contract with top five global pharma
13 June 2022 07:00
Diaceutics
-
New AI and ML Capabilities Enhance DXRX Platform
7 June 2022 07:00
Diaceutics
-
PDMR Shareholding/Share Incentive Plan
31 May 2022 12:12
Diaceutics
-
Share Options and PDMR Shareholdings
27 May 2022 16:31
Diaceutics
-
Result of AGM
26 May 2022 15:00
Diaceutics
-
PDMR Shareholding/Share Incentive Plan
11 May 2022 14:34
Diaceutics
-
Exercise of Warrant & Total Voting Rights
9 May 2022 16:37
Diaceutics
-
Contract Win
5 May 2022 07:00
Diaceutics
-
PDMR Shareholding/Share Incentive Plan
29 April 2022 17:22
Diaceutics
-
Notice of AGM and Posting of Annual Report
28 April 2022 14:09
Diaceutics
-
Purchase and Sale of Shares and PDMR Shareholdings
7 April 2022 07:00
Diaceutics
-
PDMR Shareholding/Share Incentive Plan
6 April 2022 13:13
Diaceutics
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. This news service is operated by Digital Look Ltd. Republication or redistribution of Digital Look Ltd content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Digital Look Ltd. Please see https://www.sharecast.com/newsfeedterms/index.html for our terms and conditions.
© Digital Look Ltd 1998-2022. All rights reserved.

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.